The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
Emine Atas(Medical University of Vienna), Lukas Kenner(University of Veterinary Medicine Vienna)
Cited by 113
Related Papers
PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas
|Nature Medicine|2012|125
Cell-autonomous GP130 activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth
|Molecular Cancer|2025|0